Impact of Continuous Ambulatory Peritoneal Dialysis Solutions and Clearance of Macromolecules on Polymorphonuclear Neutrophils

Montgomerie J.Z. , Kalmanson G.M. , Guze L.B. Renal failure and infection. Medicine 1968; 47: 1–32.

Mailloux L.U. , Bellucci A.G. , Wilkes B.M. Mortality in dialysis patients: analysis of the causes of death. Am J Kidney Dis 1991; 18: 326–35.

Keane W.F. , Shapiro F.L. , Raij L. Incidence and type of infections occurring in 445 chronic hemodialysis patients. TransAm SocArtiflntern Organs 1977; 23: 41–7.

Nsouli K.A. , Lazarus J.M. , Schoenbaum S.C. , Gottlieb M.N. , Lowrie E.G. , Shocair M. Bacteremic infection in hemodialysis. Arch Intern Med 1979; 139: 1255–8.

Peresecenschi G. , Blum M. , Aviram A. , Spirer Z.H. Impaired neutrophil response to acute bacterial infection in dialyzed patients ArchlnternMed 1981; 141: 1301–2.

Haag-Weber M. , Hable M. , Fiedler G. Alterations of polymorphonuclear leukocyte glycogen metabolism and glucose uptake in dialysis patients. Am J Kidney Dis 1991; 17: 562–8.

Briggs W.A. , Sillix D.M. , Mahajan S. , McDonald F.D. Leukocyte metabolism and infection in uremia. Kidney Int 1983; 24(Suppl 16): S93–6.

Haag-Weber M. , Hable M. , Schollmeyer P. , Hörl W.H. Metabolic response of neutrophils to uremia and dialysis. Kidney Int 1989; 36(Suppl 27): S293–8.

Lewis S.L. , Van Epps D.E. Neutrophil and monocyte function in chronic dialysis patients (in-depth review). Am J Kidney Dis 1987; 9: 381–95.

Salant D.J. , Glover A.M. , Anderson R. Depressed neutrophil chemotaxis in patients with chronic renal failure and after renal transplantation. J Lab Clin Med 1976; 4: 536–45.

Greene W.H. , Ray C. , Mauer S.M. , Quie P.G. The effect of hemodialysis on neutrophil chemotactic responsiveness. J Lab Clin Med 1976; 88: 971–4.

Vanholder R. , Ringoir S. Infectious morbidity and defects of phagocyte function in end-stage renal disease: a review. JASN 1993; 3: 1541–54.

Nelson J. , Ormrod D.J. , Miller T.E. Host immune status in uremia. IV. Phagocytosis and inflammatory response in vivo. Kidney Int 1983; 23: 312–19.

Paul J.L. , Roch-Arveiller M. , Man N.K. , Luong N. , Moatti N. , Raichvarg D. Influence of uremia on polymorphonuclear leukocytes oxidative metabolism in end-stage renal disease and dialyzed patients. Nephron 1991; 57: 428–32.

Vanholder R. , Ringoir S. , Dhondt A. , Hakim R. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 1991; 39: 320–7.

Waterlot Y. , Cantinieaux B. , Hariga-Muller C. , De Maertelaere-Laurent E. , Vanherweghem J.L. , Fondu P. Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: the critical role of iron overload. Br Med J 1985; 291: 501–4.

Flament J. , Goldman M. , Waterlot Y. , Dupont E. , Wybran J. , Vanherweghem J.L. Impairment of phagoctye oxidative metabolism in hemodialyzed patients with iron overload. Clin Nephrol 1986; 25: 217–30.

Cantinieaux B. , Boelaert J. , Hariga C. , Fondu P. Impaired neutrophil defense against Yersinia enterocolitica in patients with iron overload who are undergoing dialysis. J Lab Clin Med 1988; 111: 524–8.

Boelaert J.R. , Cantinieaux B.F. , Hariga C.F. , Fondu P.G. Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients. Nephrol Dial Transplant 1990; 5: 504–17.

Veys N. , Vanholder R. , Ringoir S. Correction of deficient phagocytosis during erythropoietin (EPO) treatment in maintenance haemodialysis patients. Am J Kidney Dis 1992; 19: 358–63.

Alexiewicz J.M. , Smogorzweski M. , Fadda G.Z. , Massry S.G. Impaired phagocytosis in dialysis patients: studies on mechanisms. Am J Nephrol 1991; 11: 102–11.

Haag Weber M. , Mai B. , Hörl W.H. Effect of hemodialysis on intracellular calcium in human polymorphonuclear neutrophils. Miner Electrolyte Metab 1992; 18: 151–5.

Chevru J. , Kierszteijn M. , Alexiewicz J.M. , Fadda G.Z. , Smorgorzweski M. , Massry S.G. Impaired phagocytosis in chronic renal failure is mediated by secondary hyperparathyroidism. Kidney Int 1992; 41: 1501–5.

Haag-Weber M. , Hörl W.H. Calcium dependent neutrophil activation. Contrib Nephrol Basel, Karger 1992; 100: 269–85.

Haag-Weber M. , Mai B. , Hörl W.H. Normalization of enhanced neutrophil cytosolic free calcium of hemodialysis patients by 1,25-dihydroxyvitamin D3 or calcium channel blocker Am J Nephrol 1993; 13: 467–72.

Ritchey E.E. , Wallin J.D. , Shah S.V. Chemiluminescence and superoxide anion production by leukocytes from chronic hemodialysis patients. Kidney Int 1981; 19: 349–58.

Goldblum S.E. , van Epps D.E. , Reed W.P. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis. J Clin Invest 1979; 64: 255–64.

Björkstén B. , Mauer S.M. , Mills E.L. , Quie P.G. The effect of hemodialysis on neutrophil chemotactic responsiveness. Acta Med Scand 1978; 203: 67–70.

Haag-Weber M. , Hörl W.H. Uremia and infection: mechanisms of impaired cellular host defense. Nephron 1993; 63: 125–31.

Hörl W.H. , Haag-Weber M. , Georgopoulos A. , Block L.H. Physicochemical characterization of a polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells. Proc Natl Acad Sci USA 1990; 87: 6353–7.

Lewis S.L. , Van Epps D.E. , Chenoweth D.E. Alterationsin chemotactic factor-induced responses of neutrophils and monocytes from chronic dialysis patients. Clin Nephrol 1988; 30: 63–72.

Huttunen K. , Lampainen E. , Silvennoinen-Kassinen S. , Tiilikainen A. The neutrophil function of uremic patients treated by hemodialysis or CAPD. Scand J Urol Nephrol 1984; 18: 167–72.

Rubin J. , Rogers W.A. , Taylor H.N. Peritonitis during continuous ambulatory peritoneal dialysisAnn Intern Med 1980; 92: 7–13.

Vas S. Microbiological aspects of peritonitis. Perit Dial BuZZ 1981; 1(Suppl): S11–14.

Bint A.J. , Finch R.G. , Gokal R. , Goldsmith H.J. , Junor B. , Oliver D. Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis Lancet 1987; i: 845–9.

Gokal R. , Ramos J.M. , Francis D.M. Peritonitis in continuous ambulatory peritoneal dialysis Lancet 1982; ii: 1388–91.

Kim D. , Tapson J. , Wu G. , Khanna R. , Vas S.I. , Oreopoulos D.G. Staph. aureus peritonitis in patients on continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 1984; 30: 494–7.

Harvey D.M. , Shepard K.J. , Morgan A.G. Neutrophil function in patients on continuous ambulatory peritoneal dialysis. Br J Haematol 1988; 68: 273–8.

Marichal J.F. , Faller B. , Brignon P. , Degoulet P. , Aime F. Peritonitis in continuous ambulatory peritoneal dialysis: a role for the dialysate? Nephron 1986; 42: 167–70.

Veech R.L. The untoward effects of the anions of dialysis fluids. Kidney Int 1988; 34: 587.

Topley N. , Alobaidi M.M.M. , Davies M. , Coles G.A. , Williams J.D. , Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34: 404–11.

Gallimore B. , Gagnon R.F. , Stevenson M.M. Cytotoxicity of commercial peritoneal dialysis solutions towards peritoneal cells of chronically uremic mice. Nephron 1986; 43: 283–9.

Jörres A , Jörres D. , Gahl G.M. Leukotriene B4 and tumor necrosis factor release from leukocytes: effect of peritoneal dialysate. Nephron 1991; 58: 276–82.

Duwe A.K. , Vas S.I. , Weatherhead J.W. Effects of the composition of dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 1981; 33: 130–5.

Jörres A. , Jörres D. , Topley N. , Gahl G.M. , Mahiout A. Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions. Nephrol Dial Transplant 1991; 6: 495–501.

Gordon D.L. , Rice J.L. , Avery V.M. Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1990; 9: 191–7.

Liberek T. , Topley N. , Jörres A. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 1993; 65: 260–5.

Ing B.L. , Gupta D.K. , Nawab Z.M. , Zhou F-Q , Rahaman M.A. , Daugirdas J.T. Suppression of neutrophil superoxide production by conventional peritoneal dialysis solutions. Int J ArtifOrgans 1988; 11: 351–4.

Gupta D.K. , Ing B.L. , Manahan F.J. Superoxide generation by neutrophils after exposure to a conventional peritoneal dialysis solution for different time periods. Int J ArtifOrgans 1990; 13: 228–30.

Van Bronswijk H. , Verbrugh H.A. , Meezius H.C. , van der Meulen J. , Oe P.L. , Verhoef J. Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1988; 7: 368–73.

Topley N. , Mackenzie R. , Petersen M.M. In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid. Nephrol Dial Transplant 1991; 6: 574–81.

de Fijter C.W. , Verbrugh H.A. , Peters E.D. , Vander Meulen J. , Verhoef J. , Donkev A.J. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. Clin Nephrol 1993; 39: 75–80.

Zhou F.Q. , Manahan F.J. , Yu A.W. Effects of hypertonic peritoneal dialysis solutions on neutrophil superoxide production. ArtifOrgans 1990; 14: 410–12.

Liberek T. , Topley N. , Jörres A. , Coles G.A. , Gahl G.M. , Williams J.D. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. JASN 1993; 3: 1508–15.

Wieslander A.P. , Nordin M.K. , Martinson E. , Kjellstrand P.T.I. , Boberg U.C. Heat sterilized PD fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes Clin Nephrol 1993; 39: 343–8.

Kjellstrand P. , Martinson E. , Wieslander A. Toxicity and degradation of peritoneal dialysis (PD) fluids can be decreased by using shorter sterilization times and higher temperature (Abstract). J Am Soc Nephrol 1991; 2: 362.

Keane W.F. , Comty C.M. , Verbrugh H.A. , Petersen P.K. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int 1984; 25: 539–43.

Coles G.A. , Alobaidi H.M. , Topley N. , Davies M. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis peritonitis. Nephrol Dial Transplant 1987; 2: 359–65.

Verbrugh H.A. , Keane W.F. , Hoidal J.R. , Freiberg M.R. , Elliot G.R. , Petersen P.K. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis 1983; 147: 1018–29.

Kuusela P. Fibronectin binds to Staphylococcus aureus. Nature 1978; 276: 718–20.

Abraham S.M. , Beachey E.H. , Simpson W.A. Adherence of Streptococcus pyogenes, Escherichia coli, and Pseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells Infect Immun 1983; 41: 1261–8.

Lanser M.E. , Saba T.M. Fibronectin as a co-factor necessary for optimal granulocyte phagocytosis of Staphylococcus aureus. J Reticuloendothel Soc 1981; 30: 415–24.

Goldstein C.S. , Garrick R.E. , Polin R.A. Fibronectin and complement secretion by monocytes and peritoneal macrophages in vitro from patients undergoing continuous ambulatory peritoneal dialysis. J Leukoc Biol 1986; 39: 457–64.

Holmes C. , Lewis S. Host defense mechanisms in the cavity of continuous ambulatory peritoneal dialysis patients. Second of two parts. 2. Humoral defenses. PeritDial Int 1991; 11: 112–17.

Coles G.A. , Minors S.J. , Horton J.K. Can the risk of peritonitis be predicted for new continuous ambulatory peritoneal dialysis (CAPD) patients? Perit Diallnt 1989; 9: 69–72.

McGregor S.J. , Brock J.H. , Briggs J.D. , Junor B.J.R. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989; 9: 115–19.

Young G.A. , Young J.B. , Young S.M. Nutrition and delayed hypersensitivity during continuous ambulatory peritoneal dialysis in relation to peritonitis. Nephron 1986; 43: 177–86.

Alobaidi H.M. , Coles G.A. , Davies M. , Lloyd G. Host defense in continuous ambulatory peritoneal dialysis: the effect of dialysate on phagocyte function. Nephrol Dial Transplant 1986; 1: 16–21.

Buggy B.P. , Schaberg D.R. , Swartz R.D. Intraleucocytic sequestration as a cause of persistent Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis. Am J Med 1984; 76: 1035–40.

Harvey D.M. , Sheppard K.J. , Morgan A.G. Effect of dialysate fluids on phagocytosis and killing by normal neutrophils. J Clin Microbiol 1987; 25: 1424–7.

Harvey D.M. , Morgan A.G. , Fletcher J. The polymorph neutrophils in CAPD patients. Contrib Nephrol Basel, Karger 1990; 85: 10–15.

Jörres A. , Topley N. , Steenweg L. , Müller C. , Köttgen E. , Gahl G.M. Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle. Am J Nephrol 1992; 12: 80–5.

Haag-Weber M. , Mai B. , Hörl W.H. Isolation of a granulocyte inhibitory protein from uremic patients with homology to beta2-microglobulin. Nephrol Dial Transplant (in press).

Floege J. , Granolleras C. , Binge I.M. β2-microglobulin kinetics during haemodialysis and haemofiltration. Nephrol Dial Transplant 1987; 1: 223–8.

Floege J. , Granolleras C. , Deschodt G. High-flux synthetic versus cellulosic membranes for β 2microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration. Nephrol Dial Transplant 1989; 4: 653–7.

Floege J. , Smeby L. Dialysis-related amyloidosis and high-flux membranes. Contrib Nephrol 1992; 96: 124–37.

DiRaimondo C.R. , McCarley P. , Stone W.J. Beta-2 microglobulin in peritoneal dialysis patients: serum levels and peritoneal clearances. Perit Dial Int 1988; 8: 43–7.

Sethi D. , Murphy C.M. , Brown E.A. , Müller B.R. , Gower P.E. Clearance of beta-2-microglobulin using continuous ambulatory peritoneal dialysis. Nephron 1989; 52: 352–5.

Hempelmann U. , Reinke H. , Bläser A. , Hörl W.H. , Tschesche H. Inhibition of degranulation of polymorphonuclear leukocytes by a protein identical to angiogenin (submitted for publication).

Kurachi K. , Davie E.W. , Strydom D.J. , Riordan J.F. , Vallee B.L. Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. Biochemistry 1985; 24: 5494–9.